BOC Sciences is a trusted global partner serving the life sciences, biotech, and pharmaceutical industries
Amylin-Targeting Drugs May Be the Next Wave in Obesity and Diabetes Treatment While GLP-1 medications currently dominate the weight loss and diabetes markets, several major pharmaceutical companies in addition to Roche and Zealand are now working to develop drugs that mimic amylin
Novo Nordisk, the maker of Ozempic, is named as a defendant in the multidistrict litigation for people claiming blindness from GLP-1 drugs (MDL No
This guide explains the GLP-1 vs GLP-2 distinction in plain terms, gives you a side-by-side comparison table, and untangles the "inhibitor" confusion so you know exactly what these medications are and what they do
On day two, mice were placed into the same test box in the presence of two identical objects (6 cm away from the side wall) for 20 min, after an inter-trial interval of 1 h, one familiar object was replaced with a novel object
zellikle baz tiroid hastalklar, pankreas hastalklar, gebelik ve emzirme dnemi gibi durumlarda bu ilalarn kullanm nerilmez
